GSK Plc reported a decline in sales for two of its major vaccines in the third quarter, attributed to access issues in the US. Arexvy, for respiratory syncytial virus, generated £188 million, falling short of the £290 million forecast, while Shingrix sales reached £739 million, below the expected £895 million.
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.
